IMVT
Price
$37.62
Change
-$0.48 (-1.26%)
Updated
Jun 23, 04:59 PM (EDT)
Capitalization
7.72B
50 days until earnings call
Intraday BUY SELL Signals
SLXN
Price
$2.70
Change
-$0.00 (-0.00%)
Updated
Jun 23, 04:59 PM (EDT)
Capitalization
2.85M
56 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

IMVT vs SLXN

IMVT vs SLXN Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
IMVT vs. SLXN commentary
Jun 24, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMVT is a Buy and SLXN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 24, 2026
Stock price -- (IMVT: $38.10 vs. SLXN: $2.71)
Brand notoriety: IMVT and SLXN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMVT: 136% vs. SLXN: 6%
Market capitalization -- IMVT: $7.72B vs. SLXN: $2.88M
IMVT [@Biotechnology] is valued at $7.72B. SLXN’s [@Biotechnology] market capitalization is $2.88M. The market cap for tickers in the [@Biotechnology] industry ranges from $118.89B to $0. The average market capitalization across the [@Biotechnology] industry is $2B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMVT’s FA Score shows that 0 FA rating(s) are green whileSLXN’s FA Score has 0 green FA rating(s).

  • IMVT’s FA Score: 0 green, 5 red.
  • SLXN’s FA Score: 0 green, 5 red.
According to our system of comparison, IMVT is a better buy in the long-term than SLXN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMVT’s TA Score shows that 5 TA indicator(s) are bullish while SLXN’s TA Score has 4 bullish TA indicator(s).

  • IMVT’s TA Score: 5 bullish, 4 bearish.
  • SLXN’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both IMVT and SLXN are a good buy in the short-term.

Price Growth

IMVT (@Biotechnology) experienced а +13.94% price change this week, while SLXN (@Biotechnology) price change was -1.45% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.89%. For the same industry, the average monthly price growth was +2.09%, and the average quarterly price growth was +1952.22%.

Reported Earning Dates

IMVT is expected to report earnings on Aug 12, 2026.

SLXN is expected to report earnings on Aug 18, 2026.

Industries' Descriptions

@Biotechnology (+5.89% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IMVT($7.72B) has a higher market cap than SLXN($2.85M). IMVT YTD gains are higher at: 49.882 vs. SLXN (-85.885). SLXN has higher annual earnings (EBITDA): -12.91M vs. IMVT (-532.49M). IMVT has more cash in the bank: 902M vs. SLXN (2.41M). IMVT has less debt than SLXN: IMVT (72K) vs SLXN (1.99M). IMVT (0) and SLXN (0) have equivalent revenues.
IMVTSLXNIMVT / SLXN
Capitalization7.72B2.85M270,638%
EBITDA-532.49M-12.91M4,126%
Gain YTD49.882-85.885-58%
P/E RatioN/A0.00-
Revenue00-
Total Cash902M2.41M37,381%
Total Debt72K1.99M4%
FUNDAMENTALS RATINGS
IMVT: Fundamental Ratings
IMVT
OUTLOOK RATING
1..100
34
VALUATION
overvalued / fair valued / undervalued
1..100
51
Fair valued
PROFIT vs RISK RATING
1..100
59
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
37
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IMVTSLXN
RSI
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
75%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 2 days ago
55%
Momentum
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
35%
MACD
ODDS (%)
Bullish Trend 2 days ago
89%
Bearish Trend 2 days ago
33%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
62%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
31%
Advances
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 12 days ago
54%
Declines
ODDS (%)
Bearish Trend 16 days ago
82%
Bearish Trend 2 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
80%
Bullish Trend 2 days ago
59%
Aroon
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
IMVT
Daily Signal:
Gain/Loss:
SLXN
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ZOOZ5.880.27
+4.81%
ZOOZ Strategy Ltd.
USNA18.900.02
+0.11%
USANA Health Sciences
RTACU10.760.01
+0.05%
Renatus Tactical Acquistion Corp I
ZWS49.64-0.34
-0.68%
Zurn Elkay Water Solutions Corp
SONO14.31-0.36
-2.49%
Sonos

SLXN and

Correlation & Price change

A.I.dvisor indicates that over the last year, SLXN has been loosely correlated with IMA. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if SLXN jumps, then IMA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLXN
1D Price
Change %
SLXN100%
-0.73%
IMA - SLXN
62%
Loosely correlated
-2.17%
CELC - SLXN
50%
Loosely correlated
+2.47%
CDT - SLXN
44%
Loosely correlated
+47.06%
IMVT - SLXN
42%
Loosely correlated
+7.81%
INKT - SLXN
36%
Loosely correlated
+0.54%
More